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background:  Quantity of aortic valve calcification predicts rates of perivalvular leak (PVL) post TAVR. Nonetheless, short-term outcomes 
of balloon-expandable TAVR in patients with extremely high calcified aortic valves have not been previously described.
methods:  We studied patients with severe aortic stenosis that underwent balloon-expandable TAVR and had a pre-procedural non-
contrast CT. Patients that had aortic valve calcification score (AVCS) of more than 8000 Agatston units (AU) were compared to patients 
with lower calcification scores.
results:  Seventeen patients had extreme AVCS compared to 384 with lower AVCS (mean Agatston score: 9532 vs. 3468). Device 
success was 76.5% in the extreme calcification group compared to 96.6% in patients with less calcified aortic valves (p<0.01). Second 
valve implantation was required in 17.6% compared to 3.4% respectively (p<0.01). There was significantly more postprocedural PVL in 
the high AVCS group: 47.1%, 35.3%, 11.8%, 5.9% vs. 78%, 20.9%, 1.1%, 0% for no/trace, mild, moderate and severe PVL respectively 
(p<0.01). There was one case of contained root rupture resulting in peri-annular hematoma that required no intervention. In-hospital 
mortality, new pacemaker implantation and major complications were similar between groups (Table).
Conclusion:  Balloon-expandable TAVR in patients with extreme aortic valve calcification is associated with lower device success and 
greater risk of PVL.
Table: Procedural details and In-hospital clinical outcome
AVCS ≥ 8000 Agatston units
(n=17)
AVCS < 8000 Agatston units
(n=384) p-value
Device success, % (n) 76.5 (13) 96.6 (371) <0.001
2nd valve 17.6 (3) 3.4 (13) 0.003
Postdilatation 11.8 (2) 8.6 (33) 0.65
Perivalvular leak:
None / trace
Mild
Moderate
Severe
47.1 (8)
35.3 (6)
11.8 (2)
5.9 (1)
78 (295)
20.9 (79)
1.1 (4)
0 (0)
<0.001
Aortic rupture 5.9 (1) 0.3 (1) 0.9
Mortality 0 (0) 2.1 (8) 0.55
CVA/TIA 5.9 (1) 2.9 (11) 0.48
New permanent pacemaker 5.9 (1) 7.3 (28) 0.83
